Journal
Objective To analyze the correlation between primary tumor volume (PTV) and prognosis of nasopharyngeal carcinoma (NPC) treated by intensity-modulated radiotherapy (IMRT). Methods 330 NPC patients treated by IMRT were included. Pretreatment computerized tomography image were input into tree-dimensional treatment-planning system, in which the primary tumor volume were calculated automatically. The receiver operating characteristic curve was used to determine the best cut-off point of PTV. Within the framework of UICC 2002 T stage,The PTV was divided into four groups:V1<10 cm3, V2 10-25 cm3, V3>25-50 cm3 and V4>50 cm3. Kaplan-Meier and Logrank test was used to analyze the survival, Cox proportion risk regression model were used to analysis the correlation between PTV and prognosis. Results The mean PTV for all NPC patients was (34.2±27.1) cm3 with the range of 0.4-153.7 cm3. The 3-year overall survival for V1, V2, V3 and V4 stage were 88.6%,90.0%,91.2% and 74.2%, respectively (χ2=12.83,P=0.005). There was no significant difference among V1, V2 and V3 in terms of overall survival (χ2=1.96,P=0.376). The 3-year distant metastasis-free survival and diseases-free survival or overall survival were decrease in PTV>50 cm3 and PTV≤50 cm3 (77.4%∶89.9%, χ2=7.24, P=0.007and 64.5%∶85.1%, χ2=13.95,P=0.000 or 74.2%∶90.3%, χ2=11.76,P=0.001). Multivariate analysis revealed that PTV was a adverse prognostic factors for overall survival (χ2=0.00,P=2.580). Conclusion Our data showed that the primary tumor volume had significantly impacted on the prognosis of NPC patients treated by intensity modulated radiotherapy.
Objective This study aimed to compare the clinical characteristics and prognoses of primary Waldeyer′s ring diffuse large B-cell lymphoma (DLBCL) and extranodal nasal-type NK/T-cell lymphoma (ENKTCL). Methods From 2000 to 2008, 122 patients with primary Waldeyer′s ring DLBCL and 44 patients with primary Waldeyer′s ring ENKTCL consecutively diagnosed were retrospectively compared. Patients with DLBCL usually received 4-6 cycles of CHOP-based chemotherapy followed by involved-field radiotherapy. Patients with early stage ENKTCL usually received extended-field radiotherapy with or without subsequent chemotherapy, or short courses (1-3 cycles) of chemotherapy followed by radiotherapy. Kaplan-Meier method was used for survival analysis. Logrank method was used for univariate analysis. Results The follow-up rate was 82%. The number of patients followed 5 years were 32 and 15 in DLBCL and ENKTCL. DLBCL mainly presented with stage Ⅱ tonsillar disease with regional lymph nodeinvolvement. ENKTCL occurred predominately in young males, as nasopharyngeal stageⅠ disease with B symptoms and involving adjacent structures. The 5-year overall survival (OS) and progression-free survival(PFS) rates were 74% and 67% in DLBCL, and 68% and 59% in ENKTCL (χ2=0.53,1.06,P=0.468,0.303), respectively. In stage Ⅰ and Ⅱ diseases, the 5-year OS and PFS rates were 79% and 76% forDLBCL compared to 72% and 62% for ENKTCL (χ2=1.20,2.46,P=0.273,0.117). On univariate analysis, age>60 years, elevated lactate dehydrogenase, eastern cooperative oncology group performance status>1, international prognosis index (IPI) score ≥1, stage Ⅲ/IV diseases and bulky disease were associated with unfavorable survival for DLBCL (χ2=9.40,12.72,6.15,10.36,12.48,5.53,P=0.002,0.000,0.013,0.001,0.000,0.019), and only age>60 years and IPI score ≥1 were associated with poor survival for ENKTCL (χ2=3.98,8.41,P=0.046,0.004). Conclusions These results indicate that remarkable clinical disparities exist between DLBCL and ENKTCL in Waldeyer′s ring. Different treatment strategies for each can result in similarly favorable prognoses.
Objective To investigate the efficacy and toxicity of postoperative radiochemotherapy compared with chemotherapy alone in the treatment of locally advanced gastric cancer. Methods A total of 83 patients with resected adenocarcinoma of the stomach were randomly assigned to postoperative radiochemotherapy group (RCT)(n=43) or chemotherapy alone group (CT)(n=40). Patients in RCT group received radiotherapy concurrent with capecitabine chemotherapy then followed by 4-6 cycles of FOLFOX4 chemotherapy. The total dose of radiation was 45 Gy. The dose of capecitabine was 1600 mg/m2 per day. In the CT group, patients received 6-8 cycles FOLFOX4 chemotherapy. Survival was analyzed using Kaplan-Meier method and Logrank test. Results The follow-up rate was 96%. The number of patients who had a minimum of 2-,3-year follow-up time were 37,12 in the RCT group and 31,10 in the CT group. The 1-,2-,3-year local control rates for RCT and CT groups were 100%,97%,94% and 95%,87%,73%(χ2=4.54,P=0.033), respectively. The 1-,2-,3-year survival rates were 98%,86%,81% in the RCT group, with 93%,80%,64% in the CT group (χ2=3.96,P=0.047). The incidence of grade 3 hematological toxicity in the RCT and CT group was 23% vs 15%(χ2=0.93,P=0.630), and grade 3 gastrointestinal toxicity was 16% vs 10%(χ2=0.95,P=0.624). Conclusions Compared with chemotherapy alone, postoperative radiochemotherapy can improve survival of locally advanced gastric cancer patients with acceptable toxicities.
News
Cooperation unit